These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11080789)

  • 1. Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.
    Mariuzzi L; Mombello A; Rucco V; Morelli L; Zamò A; Thompson D; Vaught L; Bartels HG; Mariuzzi G; Bartels PH
    Adv Clin Path; 2000 Apr; 4(2):87-97. PubMed ID: 11080789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
    Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
    Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative study of ductal breast cancer progression: nuclear signatures for evaluation of progression grade.
    Mombello A; Mariuzzi L; Morelli L; Granchelli G; Rucco V; Tarocco E; da Silva VD; Thompson D; Bartels HG; Bartels PH; Mariuzzi G
    Adv Clin Path; 2001 Jul; 5(3):59-70. PubMed ID: 11753877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast.
    Susnik B; Worth A; Palcic B; Poulin N; LeRiche J
    Anal Cell Pathol; 1995 Jan; 8(1):39-52. PubMed ID: 7734410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative study of ductal breast cancer progression. Morphometric evaluation of phenotypical changes occurring in benign and preinvasive epithelial lesions.
    Mariuzzi GM; Mariuzzi L; Mombello A; Santinelli A; Valli M; Rahal D; Thompson D; Bartels PH
    Pathol Res Pract; 1994 Nov; 190(11):1056-65. PubMed ID: 7746739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of nuclear grading assessed by image cytometry for node negative breast cancer patients.
    Kimijima I; Watanabe T; Abe R
    Anticancer Res; 1996; 16(6C):3949-53. PubMed ID: 9042318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computerized scene segmentation for the discrimination of architectural features in ductal proliferative lesions of the breast.
    Anderson NH; Hamilton PW; Bartels PH; Thompson D; Montironi R; Sloan JM
    J Pathol; 1997 Apr; 181(4):374-80. PubMed ID: 9196433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
    Giardina C; Serio G; Lepore G; Lettini T; Dalena AM; Pennella A; D'Eredità G; Valente T; Ricco R
    J Exp Clin Cancer Res; 2003 Jun; 22(2):279-88. PubMed ID: 12866579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry.
    Ruiz A; Almenar S; Callaghan RC; Llombart-Bosch A
    Pathol Res Pract; 1999; 195(11):741-6. PubMed ID: 10605693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia.
    Tavassoli FA
    Mod Pathol; 1998 Feb; 11(2):140-54. PubMed ID: 9504685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
    Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
    J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading.
    Sauer T; Lømo J; Garred O; Naess O
    Cancer; 2005 Feb; 105(1):21-7. PubMed ID: 15593325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Revertant' DCIS in human axillary breast carcinoma metastases.
    Barsky SH; Doberneck SA; Sternlicht MD; Grossman DA; Love SM
    J Pathol; 1997 Oct; 183(2):188-94. PubMed ID: 9390032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast.
    Diallo R; Schaefer KL; Poremba C; Shivazi N; Willmann V; Buerger H; Dockhorn-Dworniczak B; Boecker W
    J Pathol; 2001 Jan; 193(1):27-32. PubMed ID: 11169512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.